No—aspirin and ketorolac should not be taken together. Both are nonsteroidal anti-inflammatory drugs (NSAIDs) that work through the same mechanism, and combining them significantly increases the risk of serious gastrointestinal bleeding, ulceration, and other adverse events. The FDA labeling for ketorolac explicitly warns against concurrent use with other NSAIDs, including aspirin, due to the cumulative risk of GI toxicity and renal injury.
Ketorolac's FDA-approved label carries a black box warning—the agency's most severe safety designation—that applies to all NSAIDs in this class. The label states: "NSAIDs cause serious cardiovascular and gastrointestinal toxicity. Use the lowest effective dose for the shortest duration possible." Critically, the labeling explicitly contraindicates ketorolac use "in patients currently receiving aspirin or other NSAIDs."
According to FDA Adverse Event Reporting System (FAERS) data, upper gastrointestinal bleeding (UGIB) accounts for approximately 15,000 to 20,000 hospitalizations annually in the United States, with NSAIDs implicated in 25–30% of these cases. When two NSAIDs are combined, the incidence of serious GI complications rises sharply. A 2017 systematic review of NSAID safety found that concurrent use of multiple NSAIDs increased the risk of hospitalizable GI bleeding by approximately 4- to 5-fold compared to single NSAID use.
The ketorolac label further warns that "the use of ketorolac with other NSAIDs or with aspirin is contraindicated, as this may increase the frequency and severity of adverse reactions, particularly GI effects." This language reflects decades of clinical evidence and post-market surveillance showing that NSAID accumulation causes measurable harm.
Aspirin and ketorolac operate through the same pharmacological pathway: both inhibit cyclooxygenase (COX) enzymes, which produce prostaglandins. Prostaglandins serve critical protective functions in the gastrointestinal tract, including maintenance of the gastric mucosal barrier, regulation of gastric acid secretion, and preservation of gastric blood flow. When a single NSAID blocks COX enzymes, prostaglandin synthesis drops, and the GI tract becomes more vulnerable to acid damage. When two NSAIDs are administered concurrently, the effect is cumulative and dose-dependent.
Aspirin is unique among NSAIDs because it irreversibly acetylates COX-1, making even low-dose aspirin (81 mg daily for cardiovascular protection) an NSAID by definition. Ketorolac is a potent, non-selective COX inhibitor with a short half-life (4–6 hours), but its acute anti-inflammatory effect is substantially stronger than aspirin on a milligram-per-milligram basis. When combined, the two drugs produce a synergistic reduction in mucosal-protective prostaglandins, exponentially increasing ulcer risk and the likelihood of GI bleeding.
Beyond GI toxicity, both drugs inhibit renal prostaglandins, which regulate glomerular filtration rate and renal blood flow. Combined NSAID use impairs renal function more severely than either drug alone, particularly in older adults and patients with pre-existing renal disease, heart failure, or volume depletion. This renal injury can trigger acute kidney injury (AKI) and, in some cases, irreversible chronic kidney disease.
Additionally, ketorolac is metabolized primarily by the liver via glucuronidation and oxidation, while aspirin undergoes hydrolysis to salicylate. No direct metabolic competition occurs, but both drugs rely on hepatic clearance, meaning liver dysfunction can cause accumulation of either agent and heighten toxicity risk.
Certain patient populations face substantially elevated risk if exposed to both aspirin and ketorolac:
A 72-year-old man with a history of hypertension and atrial fibrillation undergoes arthroscopic knee surgery. He takes aspirin 81 mg daily for stroke prevention (as recommended for his atrial fibrillation risk) and receives ketorolac 30 mg intravenously as part of intraoperative anesthesia. Ketorolac is then prescribed as 15 mg oral every 6 hours for 7 days post-operatively.
This patient is at high risk. The combination of low-dose aspirin (which is still an NSAID) and therapeutic-dose ketorolac, in an elderly patient with reduced renal reserve, creates a perfect storm for GI toxicity and acute kidney injury. Within 3–5 days, he develops melena (black stools), indicating upper GI bleeding. His serum creatinine rises from baseline 1.1 mg/dL to 1.8 mg/dL, signaling drug-induced AKI. Endoscopy reveals gastric erosions. He requires hospitalization, blood transfusion, and discontinuation of both NSAIDs.
Better approach: Post-operative ketorolac should be avoided in patients on aspirin. Alternative pain management strategies include acetaminophen, tramadol, or opioid analgesics as appropriate for the clinical context. If ketorolac is deemed essential for pain control, aspirin should be temporarily held for the duration of ketorolac use, with careful reassessment of thromboembolic risk.
A 55-year-old woman with recurrent migraines takes aspirin 325 mg once daily for primary prevention of coronary artery disease (CAD history). She experiences a severe migraine and visits an urgent care clinic. The provider, unaware of her aspirin use, prescribes ketorolac 60 mg intramuscularly as acute migraine therapy.
The patient uses ketorolac as directed (60 mg IM), and her migraine resolves within 2 hours. However, 8 hours later, she experiences severe epigastric pain and vomiting. Blood in her vomitus prompts emergency department evaluation. Upper endoscopy reveals a large antral ulcer with active bleeding, requiring endoscopic intervention (injection therapy). Her hemoglobin drops from 13.2 g/dL to 10.1 g/dL. She is admitted, kept NPO, started on high-dose proton-pump inhibitor (PPI) therapy, and monitored for continued bleeding.
Better approach: The urgent care provider should have asked about all current medications, including low-dose and over-the-counter NSAIDs like aspirin. Migraine management in a patient on aspirin should use non-NSAID options: triptans (sumatriptan, naratriptan), dihydroergotamine, or other non-NSAID analgesics. If an NSAID is truly necessary, aspirin should be held temporarily, and a single, short-duration NSAID (e.g., ibuprofen 400 mg once) might be considered in lower-risk patients with close follow-up.
If you are currently taking aspirin: Inform your doctor or pharmacist before starting ketorolac or any other NSAID. Even if you are taking low-dose aspirin "just for heart health," it counts as an NSAID and should be disclosed. Do not use ketorolac without explicit approval from your healthcare provider.
If you are prescribed ketorolac: Ask your pharmacist to verify that you are not taking aspirin, ibuprofen, naproxen, or any other NSAID. If you are, request an alternative pain medication. If ketorolac is deemed medically necessary and aspirin can be safely held, ensure you have a clear plan for when aspirin will be restarted and at what dose.
If you need short-term pain relief and are on aspirin: Consider acetaminophen (up to 3–4 grams daily, divided doses), tramadol, or prescription opioids as alternatives, depending on your medical history and the severity of pain. Ask your pharmacist which option is safest for your specific situation.
If you have risk factors for GI bleeding or renal disease: Avoid all NSAID combinations and discuss individual NSAID use with your doctor before starting. If you have a history of peptic ulcer disease and absolutely must take an NSAID, discuss PPI co-therapy with your provider—though the safest option is to use a non-NSAID alternative.
Seek immediate medical attention if you experience any of the following while taking ketorolac (especially if you are also taking aspirin):
If you accidentally take aspirin and ketorolac together, contact Poison Control (1-800-222-1222 in the US) or your pharmacist immediately. Do not wait for symptoms to develop if you know you have taken both drugs.
This interaction is serious, but it is entirely preventable with proper medication communication. If you take aspirin—for heart health, stroke prevention, or any other reason—and are prescribed ketorolac or any other NSAID, your pharmacist can identify the conflict before you fill the prescription. Similarly, if you are already on ketorolac and considering starting aspirin, that conversation should happen with your doctor or pharmacist before you begin.
The easiest way to catch dangerous drug combinations is to use a comprehensive interaction checker that reviews your complete medication list. Visit checkdruginteractions.com to enter all of your medications—including over-the-counter drugs, supplements, and low-dose aspirin—and get an instant safety review. Our database is powered by over 250,000 FDA drug labels and is updated continuously with the latest safety data. It takes 30 seconds and could prevent a serious hospitalization. Check your interactions today.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Methotrexate and ibuprofen have a major FDA-documented interaction. Learn mechanism, monitoring, and safe management strategies for healt...
Tacrolimus and fluconazole interaction explained. Learn severity, risks, and what FDA labels say about combining these drugs.
Is it safe to take methimazole and warfarin together? Learn about this drug interaction from FDA data and pharmacology.